Highly Miniaturized Formats for In Vitro Drug Metabolism Assays Using Vivid® Fluorescent Substrates and Recombinant Human Cytochrome P450 Enzymes
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 10 (1) , 56-66
- https://doi.org/10.1177/1087057104269731
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Early prediction of drug metabolism and toxicity: systems biology approach and modelingDrug Discovery Today, 2004
- Novel detection strategies for drug discoveryDrug Discovery Today, 2002
- Improvement of “Hit-to-Lead” Optimization by Integration of in Vitro HTS Experimental Models for Early Determination of Pharmacokinetic PropertiesCombinatorial Chemistry & High Throughput Screening, 2002
- In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical developmentToxicology Letters, 2001
- Miniaturized HTS technologies – uHTSDrug Discovery Today, 2001
- In Vitro High Throughput Screening of Compounds for Favorable Metabolic Properties in Drug Discovery.Combinatorial Chemistry & High Throughput Screening, 2001
- High-Performance Liquid Chromatography Determination of N- and O-Demethylase Activities of Chemicals in Human Liver Microsomes: Application of Postcolumn Fluorescence Derivatization Using Nash ReagentAnalytical Biochemistry, 2000
- Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potentialXenobiotica, 1999
- Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymesJournal of Clinical Pharmacy & Therapeutics, 1998
- Improved high-performance liquid chromatographic method for the determination of ethylmorphine and its metabolites in microsomal incubations and cell culture mediaJournal of Chromatography B: Biomedical Sciences and Applications, 1992